GeneCraft Inc.

GeneCraft is a pre-clinical-stage biotech company dedicated to improving treatment and clinical outcomes for patients through gene therapy that harness the innate oncogene defense system.

Funding reportedLast round: Series A

PharmaceuticalsNew York, United States

What company datasets say GeneCraft Inc. raised

Funding, as reported

Reported in all$10Bin dollars

Rounds1

Last roundSeries A

Last round size$8.4M

Last round dateJan 2024

Investors listed3

The company, in detail

What they build

Known for

health careubi-aav platformoncogene defenseinnate oncogene defense systemgene therapy developmentgene therapy gene deliverymedical researchgene therapy for lung adenocarcinomagene therapy researchtargeted therapygene therapy gene engineeringgene therapy pipelinegene therapy for oncologyhospital & health careaav gene therapiesmedical

Built with from their website

Amazon AWS

Sector: Pharmaceuticals
Industry code: NAICS 541714, SIC 8731
Region: New York
Full record: Every detail in the company directory

Pharmaceuticals in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put GeneCraft Inc. in front of investors. Or tell us what we have wrong.

List your startup Send a correction